* Pediatrix Medical Group Inc MD.N MD is expected
to show a
rise in quarterly revenue when it reports results on February
20 for the period ending December 31 2023
* The Sunrise Florida-based company is expected to report a
1.8% increase in revenue to $523.341 million from $513.84
million a year ago, according to the mean estimate from 8
analysts, based on LSEG data. (Sales majority is on Net revenue
basis)
* LSEG's mean analyst estimate for Pediatrix Medical Group
Inc is
for earnings of 33 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 6
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Pediatrix
Medical
Group Inc is $10.00, above its last closing price of $9.36.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 0.43 0.43 0.32 Missed -26.1
Jun. 30 2023 0.41 0.40 0.39 Missed -3
Mar. 31 2023 0.23 0.23 0.23 Met 0.5
Dec. 31 2022 0.49 0.48 0.47 Missed -2.8
Sep. 0.54 0.55 0.40 Missed -26.9
30 2022
Jun. 30 2022 0.48 0.48 0.47 Missed -1.1
Mar. 31 2022 0.27 0.27 0.33 Beat 21.1
Dec. 31 2021 0.44 0.44 0.52 Beat 19.2
This summary was machine generated February 16 at 14:07 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)